[Intracavernous injection of vasoactive agents].
Kawanishi
Yasuo
Y
Department of Urology, Takamatsu Red Cross Hospital.
D000284:Administration, Oral; D000527:Alprostadil / Q000008:administration & dosage* / Q000494:pharmacology; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections / Q000379:methods; D008297:Male; D010413:Penis / Q000098:blood supply; D010879:Piperazines / Q000008:administration & dosage; D011687:Purines; D012039:Regional Blood Flow / Q000187:drug effects; D012646:Self Administration; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000008:administration & dosage*
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D000527:Alprostadil